Cas:132342-04-2 (-)-[(8,8-Dimethoxycamphoryl)sulfonyl]oxaziridine manufacturer & supplier

Chemical Name:(-)-[(8,8-Dimethoxycamphoryl)sulfonyl]oxaziridine

CAS.NO:132342-04-2

Synonyms:(-)-(8,8-dimethoxycamphor-sulfonyl)oxaziridine

Molecular Formula:C₁₂H₁₉NO₅S

Molecular Weight:289.34800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:76.52000

Exact Mass:289.09800

LogP:1.71730

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (-)-(8,8-dimethoxycamphor-sulfonyl)oxaziridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(-)-(8,8-dimethoxycamphor-sulfonyl)oxaziridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(-)-(8,8-dimethoxycamphor-sulfonyl)oxaziridine Use and application,(-)-(8,8-dimethoxycamphor-sulfonyl)oxaziridine technical grade,usp/ep/jp grade.

Related News: The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients. dihydrogen compound with neon (1:1) manufacturers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. Fr(I)2 suppliers Walmsley’s background in consumer health—and lack of prior experience in pharma—has reportedly been targeted by Elliott in the investment firm’s secret push for a new boss at GSK. yttrium ion vendor & factory.